Table 3 The mean per patient percentage of ‘Yes’ responses to the SEP diary questions

From: An open label, randomized, fixed-dose, crossover study comparing efficacy and safety of sildenafil citrate and saffron (Crocus sativus Linn.) for treating erectile dysfunction in men naïve to treatment

SEP diary questions Sildenafil Saffron  
  Baseline EOT P-value Baseline EOT P-value* P-value**
SEP1, ability to achieve some erection 67.4 87.5 0.01 65.9 61.4 0.1 0.001
SEP2, successful penetration 47.8 82.4 0.01 46.4 42.4 0.1 0.001
SEP3, successful intercourse 19.7 74.1 0.001 18.9 21.6 0.1 0.0001
SEP4, satisfaction with erection hardness 7.8 67.4 0.001 7.9 8.4 0.1 0.0001
SEP5, overall satisfaction with the sexual experience 6.4 62.6 0.001 6.9 6.6 0.1 0.0001
  1. Abbreviations: EOT, end of trial; SEP, Sexual Encounter Profile.
  2. *P-value vs baseline; **P-value saffron vs sildenafil.